These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 921888)

  • 21. Influence of anaesthetics on tumour-cell kill and repopulation in B16 melanoma treated with melphalan.
    Peacock JH; Stephens TC
    Br J Cancer; 1978 Dec; 38(6):725-31. PubMed ID: 743490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemopotentiation in vivo: no loss of sensitization with fractionation.
    Hill SA; Siemann DW
    Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermochemotherapy for B16 melanoma: combination therapy of hyperthermia, melphalan, and CCNU in mice.
    Vicente V; Gomez M; Ochotorena MM; Cremades A; Canteras M
    Pigment Cell Res; 1990; 3(1):1-7. PubMed ID: 2377576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY; Workman P
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience with combination therapy of solid tumors using 1-(2-chloroethyl)-3-cyclohexyl-nitrosourea--CCNU].
    Robustelli Della Cuna G
    G Ital Chemioter; 1980; 27(1):15-8. PubMed ID: 7286538
    [No Abstract]   [Full Text] [Related]  

  • 28. A clinical trial of CCNU (1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea) (NSC 79037) in advanced ovarian carcinoma.
    Sasaki TM; McConnell DB; Moseley HS; Merhoff GC; Fletcher WS
    J Surg Oncol; 1975; 7(5):347-50. PubMed ID: 1100915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
    Chang TK; Chen H; Waxman DJ
    Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to L1210 cell nuclear proteins.
    Woolley PV; Dion RL; Kohn KW; Bono VH
    Cancer Res; 1976 Apr; 36(4):1470-4. PubMed ID: 4221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two glycine containing 2-chloroethylnitrosoureas--a comparative study on some physicochemical properties, in vivo antimelanomic effects and immunomodulatory properties.
    Zheleva A; Stanilova S; Dobreva Z; Zhelev Z
    Int J Pharm; 2001 Jul; 222(2):237-42. PubMed ID: 11427354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs.
    Fodstad O; Aass N; Pihl A
    Br J Cancer; 1980 May; 41(5):829-31. PubMed ID: 7426308
    [No Abstract]   [Full Text] [Related]  

  • 34. Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.
    Twentyman PR
    Br J Cancer; 1977 Feb; 35(2):208-17. PubMed ID: 836758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
    Hirst DG; Brown JM; Hazlehurst JL
    Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Some preliminary observations on chemotherapy of infantile medulloblastomas with vincristine sulfate and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)].
    Pompili A; Cianfriglia F; Occhipinti E
    Minerva Pediatr; 1978 Nov; 30(21):1721-4. PubMed ID: 723818
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
    Povlsen CO; Jacobsen GK
    Cancer Res; 1975 Oct; 35(10):2790-6. PubMed ID: 1157050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal interactions in the Lewis lung tumour between cytotoxic drugs and acute or fractionated radiotherapy.
    Stephens TC; Adams K; Peacock JH; Steel GG
    Radiother Oncol; 1986 Feb; 5(2):137-46. PubMed ID: 3704188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The proliferative state of clonogenic cells in the Lewis lung tumour after treatment with cytotoxic agents.
    Bateman AE; Steel GG
    Cell Tissue Kinet; 1978 Sep; 11(5):445-54. PubMed ID: 569015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.